Menlo Park, CA, United States of America

Christopher Chang

This inventor holds 1 USPTO granted patent. Top assignee: Grail, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Chang. Retrieved from https://idiyas.com/inventor/christopher-chang-gxlnbybc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Christopher Chang

Introduction

Christopher Chang is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of cancer detection through his innovative work. His dedication to advancing medical technology is evident in his patent and professional endeavors.

Latest Patents

Christopher Chang holds a patent titled "Method and System of Cancer Detection Using CPG-SNP Contamination Markers." This patent represents a breakthrough in the early detection of cancer, utilizing advanced genetic markers to improve diagnostic accuracy. He has 1 patent to his name, showcasing his commitment to innovation in healthcare.

Career Highlights

Chang is currently employed at Grail, Inc., a company focused on early cancer detection through groundbreaking technologies. His role at Grail allows him to work on cutting-edge projects that aim to save lives through early diagnosis. His expertise and innovative mindset contribute significantly to the company's mission.

Collaborations

Christopher Chang collaborates with talented individuals in his field, including his coworker Ajinkya Kokate. Together, they work on advancing technologies that have the potential to revolutionize cancer detection and treatment.

Conclusion

Christopher Chang is an inspiring inventor whose work in cancer detection exemplifies the power of innovation in medicine. His contributions are paving the way for a future where early diagnosis can lead to better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…